These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22145796)

  • 1. Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
    Hoffmann F; van den Bussche H; Wiese B; Schön G; Koller D; Eisele M; Glaeske G; Scherer M; Kaduszkiewicz H
    BMC Psychiatry; 2011 Dec; 11():190. PubMed ID: 22145796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
    Mucha L; Shaohung S; Cuffel B; McRae T; Mark TL; Del Valle M
    J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.
    Zhu L; Rochon PA; Gruneir A; Wu W; Giannakeas V; Austin PC; Stall NM; McCarthy L; Alberga A; Herrmann N; Gill SS; Bronskill SE
    Drugs Aging; 2019 Sep; 36(9):875-884. PubMed ID: 31309528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic co-prescribing in nursing home residents using cholinesterase inhibitors: Potential deprescribing cascade.
    Gromek KR; Thorpe CT; Aspinall SL; Hanson LC; Niznik JD
    J Am Geriatr Soc; 2023 Jan; 71(1):77-88. PubMed ID: 36206324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem).
    Fereshtehnejad SM; Johnell K; Eriksdotter M
    Drugs Aging; 2014 Mar; 31(3):215-24. PubMed ID: 24497071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmedical influences on the use of cholinesterase inhibitors in dementia care.
    Franz CE; Barker JC; Kravitz RL; Flores Y; Krishnan S; Hinton L
    Alzheimer Dis Assoc Disord; 2007; 21(3):241-8. PubMed ID: 17804957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients.
    Maxwell CJ; Vu M; Hogan DB; Patten SB; Jantzi M; Kergoat MJ; Jetté N; Bronskill SE; Heckman G; Hirdes JP
    Drugs Aging; 2013 Jul; 30(7):569-85. PubMed ID: 23605786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study.
    Rochon PA; Gruneir A; Bell CM; Savage R; Gill SS; Wu W; Giannakeas V; Stall NM; Seitz DP; Normand SL; Zhu L; Herrmann N; McCarthy L; Faulkner C; Gurwitz JH; Austin PC; Bronskill SE
    PLoS One; 2018; 13(10):e0205524. PubMed ID: 30346974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians.
    Jeschke E; Ostermann T; Vollmar HC; Tabali M; Schad F; Matthes H
    BMC Neurol; 2011 Aug; 11():99. PubMed ID: 21824429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey.
    Seitz DP; Gruneir A; Conn DK; Rochon PA
    J Am Geriatr Soc; 2009 Dec; 57(12):2269-74. PubMed ID: 19874411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants Of Antipsychotic Drugs Prescription Among Community-Living Older Adults With Dementia: A Population-Based Study Using Health Information Systems In The Lazio Region, Italy.
    Bargagli AM; Cascini S; Agabiti N; Kirchmayer U; Marino C; Davoli M
    Clin Interv Aging; 2019; 14():2071-2083. PubMed ID: 31819389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany.
    Bohlken J; Jacob L; van den Bussche H; Kostev K
    J Alzheimers Dis; 2018; 64(3):827-833. PubMed ID: 29889071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study.
    Scharre DW; Vekeman F; Lefebvre P; Mody-Patel N; Kahler KH; Duh MS
    Drugs Aging; 2010 Nov; 27(11):903-13. PubMed ID: 20964464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
    Lee EK; Lee YJ
    Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of cholinesterase inhibitor use for dementia.
    Herrmann N; Gill SS; Bell CM; Anderson GM; Bronskill SE; Shulman KI; Fischer HD; Sykora K; Shi HS; Rochon PA
    J Am Geriatr Soc; 2007 Oct; 55(10):1517-23. PubMed ID: 17697100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy patterns in the last year of life in patients with dementia.
    Denholm R; Morris R; Payne R
    Eur J Clin Pharmacol; 2019 Nov; 75(11):1583-1591. PubMed ID: 31346649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients.
    Helou R; Rhalimi M
    J Popul Ther Clin Pharmacol; 2010; 17(3):e379-89. PubMed ID: 21041864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially inappropriate medication among people with dementia in eight European countries.
    Renom-Guiteras A; Thürmann PA; Miralles R; Klaaßen-Mielke R; Thiem U; Stephan A; Bleijlevens MHC; Jolley D; Leino-Kilpi H; Rahm Hallberg I; Saks K; Soto-Martin M; Zabalegui A; Meyer G;
    Age Ageing; 2018 Jan; 47(1):68-74. PubMed ID: 28985257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.